Alzheimer's Disease is "predictable" | Blood screening helps early diagnosis and treatment | "Anti-amyloid drugs" delay the deterioration of the disease from the source | Canossa Hospital provides a subsidized screening program and provides one-stop diagnosis and treatment services

As individuals age, the risk of developing dementia increases, with Alzheimer’s disease being the most common manifestation. The progression of this condition can result in significant challenges and serious implications for affected individuals and their families. Recently, there have been significant advancements in both screening and treatment, allowing for earlier detection and intervention. Canossa Hospital has unveiled an innovative blood test technology capable of identifying individuals at risk for Alzheimer's disease even before symptoms emerge, marking a significant step forward in early diagnosis and care. Additionally, the hospital has implemented a subsidized screening initiative, which features a discounted revolutionary blood test and a complimentary "Montreal Cognitive Assessment," aimed at offering comprehensive medical services from diagnosis to treatment.

Subsidized screening programme details 

Chinese news links:

• am730: 阿茲海默症  早期治療延緩退化
• 東方日報: 阿茲海默症易錯過治療機會　及早篩查治療有助維持認知能力
• 星島日報: 新型血液檢查 及早發現早期阿茲海默症患者
• 經濟日報: 阿茲海默症可及早發現　新型血液檢測偵查高危人士
• HK01: 60歲男患輕度認知障礙 接受抗類澱粉蛋白藥物 如常工作旅行
• U港生活: 血液檢測新突破：及早發現阿茲海默症，抗類澱粉蛋白藥物延緩腦退化